Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Why China’s rise needs to be taken with a pinch of salt
Experts at the Nordic Life Science Days suggest China’s rapid rise in the global biopharma industry could be slowing due to an oversupply of similar drugs.
Encoded Secures $275M to Advance Dravet Syndrome Gene Therapy Candidate
Encoded Therapeutics raised $275 million in Series F funding to advance its Dravet syndrome gene therapy, ETX101, into pivotal clinical trials.
South Korea Emerges as a Key Hub for Multi-Regional Clinical Trials
South Korea becomes a top destination for global clinical trials, driven by rapid patient recruitment and the end-to-end expertise of C&R Research.
Tekton Research Sites Triple Target Enrollment in Phase 2 Obesity Trial
Tekton Research significantly exceeds expectations by enrolling 60 participants in a highly competitive Phase 2 obesity clinical trial.
AI in Clinical Trials: Predictive Modeling Builds Better Study Designs
Explore how artificial intelligence and predictive modeling are transforming clinical trials by reducing risks, anticipating dropouts, and optimizing designs.
FDA Approves AstraZeneca's Etcamah (Camizestrant) for Breast Cancer
AstraZeneca secures FDA approval for camizestrant (Etcamah) in advanced breast cancer with ESR1 mutations, overcoming an earlier advisory committee defeat.
Acepodia secures FDA clearance to begin Phase I ACE723 trial
Acepodia receives FDA IND clearance to start a Phase I clinical trial evaluating ACE723, a novel antibody-drug conjugate for hepatocellular carcinoma.
MHRA Approves Moderna’s Updated COVID-19 mRNA Vaccine Spikevax
The UK's MHRA has authorized Moderna’s updated Spikevax vaccine targeting the SARS-CoV-2 XFG variant, with doses manufactured in Oxfordshire for the NHS.
Expanding Horizons for Iberdomide as Maintenance in Multiple Myeloma
Iberdomide's clinical footprint is expanding across multiple myeloma settings, showing potential as a post-transplant maintenance and frontline therapy.
Adjuvant Alectinib Maintains Manageable Safety and QoL in NSCLC
Phase 3 ALINA trial results show adjuvant alectinib provides sustained health-related quality of life and a manageable safety profile in ALK-positive NSCLC.
NIH Grants Carilion Clinic Award to Study Psilocybin for Cocaine
A Carilion Clinic researcher received an NIH award from NIDA to study the therapeutic potential of psilocybin for treating cocaine use disorder.
Merck rare tumour drug Ezmekly backed for NHS use
NICE recommends Merck KGaA's oral MEK inhibitor Ezmekly for routine NHS use, providing a new treatment for neurofibromatosis type 1 in children and adults.
1
2
3
4
5
6
7
8
9
